From July 1, 2021 to September 30, 2021, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on December 10, 2020.
Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.48 USD | +0.25% | -1.06% | -34.85% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 03 | Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.85% | 2.23B | |
-2.32% | 185B | |
-3.52% | 105B | |
-4.95% | 66.59B | |
+2.95% | 54.66B | |
+17.03% | 47.78B | |
+4.06% | 41.26B | |
+2.61% | 26.95B | |
+2.64% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on December 10, 2020.